| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | axon guidance receptor activity | 8.59e-05 | 13 | 137 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | linear polyubiquitin binding | 1.40e-04 | 3 | 137 | 2 | GO:1990450 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.81e-04 | 308 | 137 | 9 | GO:0008017 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 SYNM SIPA1L3 OBSCN LAMA3 PTK7 GJD3 TLN1 DLG2 TLN2 PLEKHA7 PCDH1 NOTCH1 | 1.63e-04 | 591 | 139 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | LUBAC complex | 2.61e-04 | 4 | 139 | 2 | GO:0071797 | |
| GeneOntologyCellularComponent | extracellular matrix | OLFML2B HAPLN4 LAMA3 EMILIN3 MUC5B TECTA MMP25 SSC5D HMCN2 GLG1 ANGPT4 ADAMTSL4 SOD3 | 4.43e-04 | 656 | 139 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | spindle pole | 4.51e-04 | 205 | 139 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | external encapsulating structure | OLFML2B HAPLN4 LAMA3 EMILIN3 MUC5B TECTA MMP25 SSC5D HMCN2 GLG1 ANGPT4 ADAMTSL4 SOD3 | 4.56e-04 | 658 | 139 | 13 | GO:0030312 |
| MousePheno | hypochlorhydria | 1.90e-05 | 7 | 116 | 3 | MP:0008001 | |
| Domain | Growth_fac_rcpt_ | 2.10e-05 | 156 | 138 | 8 | IPR009030 | |
| Domain | - | 5.42e-05 | 2 | 138 | 2 | 1.20.1420.10 | |
| Domain | VBS | 5.42e-05 | 2 | 138 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 5.42e-05 | 2 | 138 | 2 | IPR015009 | |
| Domain | Talin_cent | 5.42e-05 | 2 | 138 | 2 | IPR015224 | |
| Domain | DUF5050 | 5.42e-05 | 2 | 138 | 2 | IPR032485 | |
| Domain | Talin_middle | 5.42e-05 | 2 | 138 | 2 | PF09141 | |
| Domain | DUF5050 | 5.42e-05 | 2 | 138 | 2 | PF16472 | |
| Domain | DH_1 | 1.02e-04 | 63 | 138 | 5 | PS00741 | |
| Domain | zf-RING_UBOX | 1.11e-04 | 34 | 138 | 4 | PF13445 | |
| Domain | Znf-RING_LisH | 1.11e-04 | 34 | 138 | 4 | IPR027370 | |
| Domain | RhoGEF | 1.47e-04 | 68 | 138 | 5 | SM00325 | |
| Domain | Talin-1 | 1.62e-04 | 3 | 138 | 2 | IPR015710 | |
| Domain | RhoGEF | 1.69e-04 | 70 | 138 | 5 | PF00621 | |
| Domain | DH_2 | 1.69e-04 | 70 | 138 | 5 | PS50010 | |
| Domain | - | 1.80e-04 | 71 | 138 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.80e-04 | 71 | 138 | 5 | IPR000219 | |
| Domain | ZF_BBOX | 3.16e-04 | 80 | 138 | 5 | PS50119 | |
| Domain | ILWEQ_dom | 3.22e-04 | 4 | 138 | 2 | IPR002558 | |
| Domain | ILWEQ | 3.22e-04 | 4 | 138 | 2 | SM00307 | |
| Domain | FERM_f0 | 3.22e-04 | 4 | 138 | 2 | PF16511 | |
| Domain | ILWEQ | 3.22e-04 | 4 | 138 | 2 | PD011820 | |
| Domain | - | 3.22e-04 | 4 | 138 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 3.22e-04 | 4 | 138 | 2 | PF01608 | |
| Domain | I_LWEQ | 3.22e-04 | 4 | 138 | 2 | PS50945 | |
| Domain | ICAM | 3.22e-04 | 4 | 138 | 2 | IPR003988 | |
| Domain | FERM_f0 | 3.22e-04 | 4 | 138 | 2 | IPR032425 | |
| Domain | Znf_B-box | 3.34e-04 | 81 | 138 | 5 | IPR000315 | |
| Domain | EGF_CA | 4.41e-04 | 86 | 138 | 5 | PF07645 | |
| Domain | EGF-like_dom | 5.34e-04 | 249 | 138 | 8 | IPR000742 | |
| Domain | ICAM_N | 5.34e-04 | 5 | 138 | 2 | PF03921 | |
| Domain | ICAM_N | 5.34e-04 | 5 | 138 | 2 | IPR013768 | |
| Domain | - | ARHGEF28 TRIO OBSCN ARHGEF18 ARHGEF11 SPTBN5 TLN1 TLN2 PLEKHA7 AGAP3 | 6.62e-04 | 391 | 138 | 10 | 2.30.29.30 |
| Domain | EGF_Ca-bd_CS | 7.66e-04 | 97 | 138 | 5 | IPR018097 | |
| Domain | ICAM_VCAM_N | 7.97e-04 | 6 | 138 | 2 | IPR003987 | |
| Domain | EGF_2 | 8.02e-04 | 265 | 138 | 8 | PS01186 | |
| Domain | EGF_CA | 8.40e-04 | 99 | 138 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.79e-04 | 100 | 138 | 5 | PS00010 | |
| Domain | PH | 1.09e-03 | 278 | 138 | 8 | SM00233 | |
| Domain | Vinculin/catenin | 1.11e-03 | 7 | 138 | 2 | IPR006077 | |
| Domain | PH_DOMAIN | 1.12e-03 | 279 | 138 | 8 | PS50003 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.14e-03 | 106 | 138 | 5 | IPR000152 | |
| Domain | PH_domain | 1.14e-03 | 280 | 138 | 8 | IPR001849 | |
| Domain | Spectrin_repeat | 1.25e-03 | 29 | 138 | 3 | IPR002017 | |
| Domain | PH_dom-like | ARHGEF28 TRIO OBSCN ARHGEF18 ARHGEF11 SPTBN5 TLN1 TLN2 PLEKHA7 AGAP3 | 1.27e-03 | 426 | 138 | 10 | IPR011993 |
| Domain | Cadherin_CS | 1.29e-03 | 109 | 138 | 5 | IPR020894 | |
| Domain | Znf_RING_CS | 1.34e-03 | 163 | 138 | 6 | IPR017907 | |
| Domain | Cadherin_2 | 1.36e-03 | 65 | 138 | 4 | PF08266 | |
| Domain | Cadherin_N | 1.36e-03 | 65 | 138 | 4 | IPR013164 | |
| Domain | DAD_dom | 1.47e-03 | 8 | 138 | 2 | IPR014767 | |
| Domain | DAD | 1.47e-03 | 8 | 138 | 2 | PS51231 | |
| Domain | CADHERIN_1 | 1.52e-03 | 113 | 138 | 5 | PS00232 | |
| Domain | Cadherin | 1.52e-03 | 113 | 138 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.58e-03 | 114 | 138 | 5 | PS50268 | |
| Domain | - | 1.58e-03 | 114 | 138 | 5 | 2.60.40.60 | |
| Domain | CA | 1.64e-03 | 115 | 138 | 5 | SM00112 | |
| Domain | SPEC | 1.67e-03 | 32 | 138 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.67e-03 | 32 | 138 | 3 | IPR018159 | |
| Domain | BBOX | 1.70e-03 | 69 | 138 | 4 | SM00336 | |
| Domain | Cadherin-like | 1.70e-03 | 116 | 138 | 5 | IPR015919 | |
| Domain | Znf_C3HC4_RING-type | 1.76e-03 | 172 | 138 | 6 | IPR018957 | |
| Domain | EGF | 1.83e-03 | 235 | 138 | 7 | SM00181 | |
| Domain | IGc2 | 1.83e-03 | 235 | 138 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.83e-03 | 235 | 138 | 7 | IPR003598 | |
| Domain | Cadherin | 1.84e-03 | 118 | 138 | 5 | IPR002126 | |
| Domain | - | 1.89e-03 | 71 | 138 | 4 | 4.10.45.10 | |
| Domain | zf-B_box | 1.99e-03 | 72 | 138 | 4 | PF00643 | |
| Domain | EGF_CA | 2.13e-03 | 122 | 138 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.28e-03 | 124 | 138 | 5 | IPR001881 | |
| Domain | EGF | 2.45e-03 | 126 | 138 | 5 | PF00008 | |
| Domain | GBD/FH3_dom | 2.85e-03 | 11 | 138 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.85e-03 | 11 | 138 | 2 | PS51232 | |
| Domain | EGF_1 | 2.90e-03 | 255 | 138 | 7 | PS00022 | |
| Domain | Ig_I-set | 2.90e-03 | 190 | 138 | 6 | IPR013098 | |
| Domain | I-set | 2.90e-03 | 190 | 138 | 6 | PF07679 | |
| Domain | GDS_CDC24_CS | 2.97e-03 | 39 | 138 | 3 | IPR001331 | |
| Domain | EGF-like_CS | 3.30e-03 | 261 | 138 | 7 | IPR013032 | |
| Domain | C8 | 3.41e-03 | 12 | 138 | 2 | PF08742 | |
| Domain | TIL | 3.41e-03 | 12 | 138 | 2 | PF01826 | |
| Domain | Kinesin-like_fam | 3.92e-03 | 43 | 138 | 3 | IPR027640 | |
| Domain | Unchr_dom_Cys-rich | 4.01e-03 | 13 | 138 | 2 | IPR014853 | |
| Domain | C8 | 4.01e-03 | 13 | 138 | 2 | SM00832 | |
| Domain | IG | 4.11e-03 | 421 | 138 | 9 | SM00409 | |
| Domain | Ig_sub | 4.11e-03 | 421 | 138 | 9 | IPR003599 | |
| Domain | - | 4.19e-03 | 44 | 138 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.19e-03 | 44 | 138 | 3 | PF00225 | |
| Domain | KISc | 4.19e-03 | 44 | 138 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.19e-03 | 44 | 138 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.19e-03 | 44 | 138 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.19e-03 | 44 | 138 | 3 | PS50067 | |
| Domain | TIL_dom | 4.65e-03 | 14 | 138 | 2 | IPR002919 | |
| Domain | IBR | 4.65e-03 | 14 | 138 | 2 | PF01485 | |
| Domain | IRS | 4.65e-03 | 14 | 138 | 2 | PF02174 | |
| Domain | IRS_PTB | 4.65e-03 | 14 | 138 | 2 | IPR002404 | |
| Domain | Ldl_recept_b | 4.65e-03 | 14 | 138 | 2 | PF00058 | |
| Domain | LDLRB | 4.65e-03 | 14 | 138 | 2 | PS51120 | |
| Domain | FH2 | 5.34e-03 | 15 | 138 | 2 | PS51444 | |
| Domain | FH2_Formin | 5.34e-03 | 15 | 138 | 2 | IPR015425 | |
| Domain | FH2 | 5.34e-03 | 15 | 138 | 2 | PF02181 | |
| Domain | LY | 5.34e-03 | 15 | 138 | 2 | SM00135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION | 7.03e-06 | 6 | 101 | 3 | M47899 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 7.99e-06 | 142 | 101 | 8 | MM15431 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.45e-05 | 154 | 101 | 8 | M27697 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.86e-05 | 46 | 101 | 5 | M68 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.40e-05 | 52 | 101 | 5 | MM14743 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 6.30e-05 | 59 | 101 | 5 | M11215 | |
| Pathway | KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM | 6.73e-05 | 31 | 101 | 4 | M766 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.43e-04 | 70 | 101 | 5 | MM14824 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.11e-04 | 76 | 101 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.24e-04 | 77 | 101 | 5 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.68e-04 | 80 | 101 | 5 | M800 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 3.56e-04 | 85 | 101 | 5 | MM14746 | |
| Pubmed | TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization. | 3.75e-09 | 6 | 140 | 4 | 36178239 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 26196062 | ||
| Pubmed | TRIM50 protein regulates vesicular trafficking for acid secretion in gastric parietal cells. | 6.38e-08 | 3 | 140 | 3 | 22872646 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | SYNM SIPA1L3 ARHGEF18 CNTROB ALMS1 SEC16A LRP1 NOTCH1 CCDC102A | 6.44e-08 | 184 | 140 | 9 | 32908313 |
| Pubmed | CACNA1E DNAJC13 TRIO SIPA1L3 ARHGEF18 ZNFX1 TRIM21 FYCO1 ARHGEF11 ZNF462 ICAM5 SEC16A LRP1 CDK5RAP2 DLG2 TLN2 PCDH8 SMG6 | 6.99e-08 | 963 | 140 | 18 | 28671696 | |
| Pubmed | 2.33e-07 | 214 | 140 | 9 | 22199357 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 26577923 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT4 PSMA2 CNTRL OBSCN FAM161B TRIM21 FYCO1 KRT73 VPS13D SEC16A HAL PLEC CCDC102A | 5.14e-07 | 564 | 140 | 13 | 21565611 |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 27893701 | ||
| Pubmed | SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. | 6.35e-07 | 5 | 140 | 3 | 21455181 | |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 20049703 | ||
| Pubmed | Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase. | 6.35e-07 | 5 | 140 | 3 | 18398435 | |
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 29604308 | ||
| Pubmed | Site-specific ubiquitination of the E3 ligase HOIP regulates apoptosis and immune signaling. | 1.27e-06 | 6 | 140 | 3 | 33215740 | |
| Pubmed | The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. | 1.27e-06 | 6 | 140 | 3 | 23453807 | |
| Pubmed | The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC. | 2.21e-06 | 7 | 140 | 3 | 32019898 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 26025256 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 23104095 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 30913450 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | BCL2L11 TRIO KIF26A SPEG SIPA1L3 OBSCN FYCO1 ARHGEF11 CNTROB TLN1 SEC16A NINL TLN2 PLEC NOTCH1 SMG6 AGAP3 | 2.41e-06 | 1105 | 140 | 17 | 35748872 |
| Pubmed | A protein quality control pathway regulated by linear ubiquitination. | 3.52e-06 | 8 | 140 | 3 | 30886048 | |
| Pubmed | SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. | 3.52e-06 | 8 | 140 | 3 | 21455180 | |
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 23032186 | ||
| Pubmed | 3.89e-06 | 225 | 140 | 8 | 12168954 | ||
| Pubmed | DCHS2 SPAST TRIO SYNM SIPA1L3 ZNFX1 CBFB LRP1B BRWD3 RBCK1 LRP1 MAP3K10 DLG2 TLN2 PLEC ALDH5A1 PINK1 AGAP3 | 4.39e-06 | 1285 | 140 | 18 | 35914814 | |
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 28249776 | ||
| Pubmed | The ubiquitin ligase HOIL-1L regulates immune responses by interacting with linear ubiquitin chains. | 5.27e-06 | 9 | 140 | 3 | 34755089 | |
| Pubmed | Crosstalk Between NDP52 and LUBAC in Innate Immune Responses, Cell Death, and Xenophagy. | 5.27e-06 | 9 | 140 | 3 | 33815386 | |
| Pubmed | Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. | 5.27e-06 | 9 | 140 | 3 | 23032187 | |
| Pubmed | LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. | 5.27e-06 | 9 | 140 | 3 | 21811235 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 34610306 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 25220058 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJC13 TRIO SIPA1L3 PRR5 OBSCN LAMA3 ARHGEF18 TECTA MAP3K12 BRWD3 HEXIM2 PTK7 ZNF462 GTF3C1 LRP1 GPT2 PCDH1 SMG6 AGAP3 | 8.82e-06 | 1489 | 140 | 19 | 28611215 |
| Pubmed | 1.03e-05 | 11 | 140 | 3 | 23732909 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGEF28 SPAST TRIO SIPA1L3 PRR5 FSIP2 VPS13D ALMS1 SEC16A MAP3K10 PLEC PLEKHA7 CCDC102A AGAP3 | 1.07e-05 | 861 | 140 | 14 | 36931259 |
| Pubmed | Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. | 1.37e-05 | 12 | 140 | 3 | 19136968 | |
| Pubmed | The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. | 1.37e-05 | 12 | 140 | 3 | 22607974 | |
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 30755793 | ||
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 27552911 | ||
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 26670046 | ||
| Pubmed | SIPA1L3 CNTROB ALMS1 SEC16A NINL PLEKHA7 FMNL1 NOTCH1 AGAP3 NIN | 1.42e-05 | 446 | 140 | 10 | 24255178 | |
| Pubmed | 1.51e-05 | 130 | 140 | 6 | 12421765 | ||
| Pubmed | Liver X receptors agonists suppress NLRP3 inflammasome activation. | 1.61e-05 | 2 | 140 | 2 | 27987394 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.61e-05 | 2 | 140 | 2 | 15963947 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11956314 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37951199 | ||
| Pubmed | RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31. | 1.61e-05 | 2 | 140 | 2 | 35869046 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24522927 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24030825 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 1.61e-05 | 2 | 140 | 2 | 26523364 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15185077 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36702106 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22117198 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29797489 | ||
| Pubmed | Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury. | 1.61e-05 | 2 | 140 | 2 | 24778451 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22306379 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18342854 | ||
| Pubmed | The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. | 1.61e-05 | 2 | 140 | 2 | 24958845 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24391143 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32947010 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26008899 | ||
| Pubmed | 1.77e-05 | 13 | 140 | 3 | 37431163 | ||
| Pubmed | --LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation. | 1.77e-05 | 13 | 140 | 3 | 27810922 | |
| Pubmed | Direct activation of protein kinases by unanchored polyubiquitin chains. | 1.77e-05 | 13 | 140 | 3 | 19675569 | |
| Pubmed | Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. | 2.25e-05 | 14 | 140 | 3 | 32123171 | |
| Pubmed | 2.75e-05 | 43 | 140 | 4 | 12376548 | ||
| Pubmed | Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. | 2.80e-05 | 15 | 140 | 3 | 23986494 | |
| Pubmed | 2.80e-05 | 15 | 140 | 3 | 20005846 | ||
| Pubmed | 2.92e-05 | 146 | 140 | 6 | 21399614 | ||
| Pubmed | PLIN4 ARHGEF28 SYNM SIPA1L3 ARHGEF18 SEMA4G ZNF462 SMYD4 VPS13D ALMS1 | 3.32e-05 | 493 | 140 | 10 | 15368895 | |
| Pubmed | 3.44e-05 | 16 | 140 | 3 | 22792322 | ||
| Pubmed | 4.17e-05 | 17 | 140 | 3 | 21082674 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO SIPA1L3 CNTRL ARHGEF11 LRP1B VPS52 ALMS1 TLN1 NINL PLEC PLEKHA7 CBX8 NIN | 4.36e-05 | 853 | 140 | 13 | 28718761 |
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 4.81e-05 | 3 | 140 | 2 | 12422220 | |
| Pubmed | Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders. | 4.81e-05 | 3 | 140 | 2 | 32403254 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 22725134 | ||
| Pubmed | Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB. | 4.81e-05 | 3 | 140 | 2 | 33392484 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 35851409 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 18792400 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 29665074 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 33992596 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 22665520 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 4.81e-05 | 3 | 140 | 2 | 17202407 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 36685275 | ||
| Pubmed | Identification and molecular analysis of RNF31 Q622H germline polymorphism. | 4.81e-05 | 3 | 140 | 2 | 36276481 | |
| Pubmed | Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis. | 4.81e-05 | 3 | 140 | 2 | 24418540 | |
| Pubmed | Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of RNF31. | 4.81e-05 | 3 | 140 | 2 | 27669734 | |
| Pubmed | A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex. | 4.81e-05 | 3 | 140 | 2 | 22430200 | |
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 4.81e-05 | 3 | 140 | 2 | 30028837 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19952892 | ||
| Pubmed | Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. | 4.81e-05 | 3 | 140 | 2 | 24141947 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 19160486 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 4.81e-05 | 3 | 140 | 2 | 27816808 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 16254247 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 26525107 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 31229841 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 4.81e-05 | 3 | 140 | 2 | 15494027 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 4.81e-05 | 3 | 140 | 2 | 26634421 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 34965468 | ||
| Interaction | KRT19 interactions | KRT4 RNF31 SYNM ARHGEF11 CNTROB KRT73 ALMS1 USHBP1 NINL CDK5RAP2 PLEC NIN | 5.67e-07 | 282 | 138 | 12 | int:KRT19 |
| Interaction | SASS6 interactions | 1.52e-06 | 159 | 138 | 9 | int:SASS6 | |
| Interaction | SQSTM1 interactions | DNAJC13 ARHGEF28 RNF31 TRIO SIPA1L3 CNTRL ACOT7 IKBKG EMILIN3 ARHGEF18 FHOD3 TRIM21 PHGDH NLRP3 ALMS1 GLG1 GJD3 SEC16A CDK5RAP2 TRIM50 NOTCH1 SOD3 PINK1 CCDC102A | 4.41e-06 | 1257 | 138 | 24 | int:SQSTM1 |
| Interaction | CCDC138 interactions | 2.22e-05 | 123 | 138 | 7 | int:CCDC138 | |
| Interaction | TNRC6A interactions | 2.37e-05 | 280 | 138 | 10 | int:TNRC6A | |
| Interaction | TRIM37 interactions | SYNM SIPA1L3 IKBKG ARHGEF18 TRIM21 CNTROB ALMS1 BBS7 SEC16A LRP1 NINL CDK5RAP2 PLEC NOTCH1 CCDC102A | 2.82e-05 | 630 | 138 | 15 | int:TRIM37 |
| Interaction | SPATA2 interactions | 2.96e-05 | 87 | 138 | 6 | int:SPATA2 | |
| Interaction | CCDC14 interactions | 3.02e-05 | 129 | 138 | 7 | int:CCDC14 | |
| Interaction | KRT18 interactions | KRT4 RNF31 SIPA1L3 IKBKG CNTROB PHGDH KRT73 ALMS1 BBS7 SEC16A PLEC NIN | 3.21e-05 | 419 | 138 | 12 | int:KRT18 |
| Interaction | STIL interactions | 5.03e-05 | 190 | 138 | 8 | int:STIL | |
| Interaction | KRT8 interactions | RNF31 SYNM SIPA1L3 IKBKG CNTROB KRT73 ALMS1 SEC16A NINL CDK5RAP2 PLEC NIN | 5.26e-05 | 441 | 138 | 12 | int:KRT8 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.35e-04 | 66 | 97 | 4 | 722 | |
| GeneFamily | Ring finger proteins | 6.99e-04 | 275 | 97 | 7 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.71e-03 | 95 | 97 | 4 | 59 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.75e-03 | 161 | 97 | 5 | 593 | |
| GeneFamily | Non-clustered protocadherins | 1.82e-03 | 12 | 97 | 2 | 21 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.92e-03 | 46 | 97 | 3 | 622 | |
| GeneFamily | Low density lipoprotein receptors | 2.14e-03 | 13 | 97 | 2 | 634 | |
| GeneFamily | Immunoglobulin like domain containing | 3.84e-03 | 193 | 97 | 5 | 594 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 5.60e-03 | 21 | 97 | 2 | 89 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-09 | 186 | 140 | 9 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.44e-08 | 199 | 140 | 9 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-06 | 170 | 140 | 7 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-06 | 178 | 140 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-06 | 178 | 140 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-06 | 185 | 140 | 7 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 186 | 140 | 7 | 61de94c9ba90e7b6780694199c059c798b1488ae | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 187 | 140 | 7 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 187 | 140 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-06 | 189 | 140 | 7 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 191 | 140 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 191 | 140 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 193 | 140 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 193 | 140 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.26e-06 | 199 | 140 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.26e-06 | 199 | 140 | 7 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-06 | 200 | 140 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.25e-05 | 162 | 140 | 6 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 172 | 140 | 6 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 174 | 140 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.27e-05 | 180 | 140 | 6 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.27e-05 | 180 | 140 | 6 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.42e-05 | 182 | 140 | 6 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.42e-05 | 182 | 140 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 185 | 140 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 185 | 140 | 6 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-05 | 186 | 140 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.73e-05 | 186 | 140 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 186 | 140 | 6 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 186 | 140 | 6 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-05 | 186 | 140 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-05 | 186 | 140 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 187 | 140 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 188 | 140 | 6 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 188 | 140 | 6 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.90e-05 | 188 | 140 | 6 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 100eda87ac9c38dddcfa58408b057867a1738acb | |
| ToppCell | facs-Trachea-nan-18m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 5ced78f4b5c276b1bab24df807c00cf5ac8ed3d4 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 2105d8b011b93a460237e00bc029efd7762dc8d5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-05 | 189 | 140 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.17e-05 | 191 | 140 | 6 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 191 | 140 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-05 | 192 | 140 | 6 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.36e-05 | 193 | 140 | 6 | a6694b33adcdb17cdd1567eb9507dbf06e6468d8 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 3.46e-05 | 194 | 140 | 6 | cf2480cc40f3c9be837b3934547e2ce30bd4fcd3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 194 | 140 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.46e-05 | 194 | 140 | 6 | 3c661c6768c3f05d2aba03d329adb257ca201b2d | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 194 | 140 | 6 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 194 | 140 | 6 | 7bf6edefd13047e04665dbe34051ef3f481f85a4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 194 | 140 | 6 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 194 | 140 | 6 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-05 | 194 | 140 | 6 | 19e5beae2c1f8bf42cbe618e89810ce7b01a396c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 195 | 140 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.66e-05 | 196 | 140 | 6 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 196 | 140 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.66e-05 | 196 | 140 | 6 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-05 | 198 | 140 | 6 | 2ae9564da9913510141994262f3739eb095e0a68 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-05 | 199 | 140 | 6 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.98e-05 | 199 | 140 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.10e-05 | 200 | 140 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.20e-05 | 122 | 140 | 5 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-05 | 124 | 140 | 5 | e9b6fdac2bef4bf1fee6a486f4628b68adc80f57 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-05 | 138 | 140 | 5 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.08e-05 | 140 | 140 | 5 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 8.64e-05 | 142 | 140 | 5 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-05 | 145 | 140 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 152 | 140 | 5 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 152 | 140 | 5 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-04 | 155 | 140 | 5 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.37e-04 | 32 | 140 | 3 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.37e-04 | 32 | 140 | 3 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 157 | 140 | 5 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 159 | 140 | 5 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 159 | 140 | 5 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 162 | 140 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 162 | 140 | 5 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-04 | 163 | 140 | 5 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-04 | 163 | 140 | 5 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 167 | 140 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 167 | 140 | 5 | 9280558baddea51aae47f3383d895a9b0c6749a4 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.85e-04 | 167 | 140 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-04 | 168 | 140 | 5 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 168 | 140 | 5 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 169 | 140 | 5 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 169 | 140 | 5 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 169 | 140 | 5 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.95e-04 | 169 | 140 | 5 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.01e-04 | 170 | 140 | 5 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 170 | 140 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 92 | 140 | 4 | a5b89f971b904b8e280fe66996a7f8efd92c2132 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Sln_(Unipolar_brush_cell)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 92 | 140 | 4 | b867cd7923585b13beaf086c40781bab2d7b7434 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 171 | 140 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 171 | 140 | 5 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 171 | 140 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.06e-04 | 171 | 140 | 5 | f49dfe11ae66d82125b577c48345a13683d7bb7b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 171 | 140 | 5 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 172 | 140 | 5 | a03f30a996a9474ad4cccd209476423a042df002 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 172 | 140 | 5 | f92a53ad2e464cd68ba1714bcc1d5911479cdf1c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 172 | 140 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 173 | 140 | 5 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| Disease | POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY | 2.17e-05 | 2 | 138 | 2 | C4014605 | |
| Disease | creatinine measurement | PLIN4 DNAJC13 BRIP1 SPEG SIPA1L3 OBSCN ARHGEF18 NR1H3 CUBN BRWD3 ALMS1 DCAF12L1 PLEC PLEKHA7 SOD3 | 6.83e-05 | 995 | 138 | 15 | EFO_0004518 |
| Disease | epilepsy (implicated_via_orthology) | 1.22e-04 | 163 | 138 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TBXAS1 BRIP1 SPAST OBSCN HAPLN4 GIMAP1 CUBN TECTA CBFB PHGDH ICAM5 EXOC3L1 SPOCD1 PCDH8 NOTCH1 | 1.58e-04 | 1074 | 138 | 15 | C0006142 |
| Disease | irritable bowel syndrome (implicated_via_orthology) | 2.15e-04 | 5 | 138 | 2 | DOID:9778 (implicated_via_orthology) | |
| Disease | intelligence, response to cranial radiation therapy | 3.01e-04 | 28 | 138 | 3 | EFO_0004337, EFO_0010950 | |
| Disease | diastolic blood pressure, systolic blood pressure | BRIP1 SPEG EMILIN3 CNTROB PTK7 ADRA1D ALMS1 USHBP1 SEC16A LRP1 TLN2 | 3.24e-04 | 670 | 138 | 11 | EFO_0006335, EFO_0006336 |
| Disease | right ventricular ejection fraction measurement | 3.70e-04 | 30 | 138 | 3 | EFO_0021816 | |
| Disease | neuroimaging measurement | DCHS2 ARHGEF11 PTK7 ZNF462 GADD45G GJD3 NINL DLG2 TLN2 PLEC PLEKHA7 CBX8 SMG6 AGAP3 | 5.03e-04 | 1069 | 138 | 14 | EFO_0004346 |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Macrocephaly | 1.16e-03 | 11 | 138 | 2 | C0221355 | |
| Disease | homocysteine measurement | 1.31e-03 | 46 | 138 | 3 | EFO_0004578 | |
| Disease | intercellular adhesion molecule 5 measurement | 1.64e-03 | 13 | 138 | 2 | EFO_0008164 | |
| Disease | fibrinogen measurement | 1.74e-03 | 109 | 138 | 4 | EFO_0004623 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.90e-03 | 14 | 138 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | neuroblastoma | 2.19e-03 | 116 | 138 | 4 | EFO_0000621 | |
| Disease | forehead morphology measurement | 2.19e-03 | 15 | 138 | 2 | EFO_0007844 | |
| Disease | Proteinuria | 2.19e-03 | 15 | 138 | 2 | HP_0000093 | |
| Disease | Congenital total cataract | 2.50e-03 | 16 | 138 | 2 | C0266539 | |
| Disease | triiodothyronine measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0008392 | |
| Disease | migraine without aura, susceptibility to, 4 | 2.50e-03 | 16 | 138 | 2 | MONDO_0011847 | |
| Disease | blood metabolite measurement | 3.52e-03 | 19 | 138 | 2 | EFO_0005664 | |
| Disease | X-24309 measurement | 3.90e-03 | 20 | 138 | 2 | EFO_0800872 | |
| Disease | Abdominal Aortic Aneurysm | 4.02e-03 | 68 | 138 | 3 | EFO_0004214 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSCQREAARLAERN | 166 | Q8N6Y0 | |
| NGERCVAALARVERT | 96 | O00154 | |
| GQEVNEAACDIARQV | 96 | Q93088 | |
| SASQGVNCIREDVAA | 151 | Q8TD30 | |
| ARRAGSQECADILIQ | 826 | Q96P47 | |
| LVCRGADERTQAAER | 606 | Q86VI1 | |
| EECRSVIQEQAAALG | 961 | Q86US8 | |
| ACQDRVLRVLQGSDV | 166 | Q8IWZ6 | |
| GQDARERRECVNGHQ | 286 | Q6ZSZ5 | |
| TGQEEFRQACERALE | 881 | Q7Z7A1 | |
| RQVRCVGNNGDEVSE | 806 | Q6UY14 | |
| DVSRCNSEERGTQAD | 2096 | Q15878 | |
| SDVFCGRVQCENVRD | 556 | Q9UKJ8 | |
| DDQGRCQEGLRTLAE | 316 | Q9HC16 | |
| LDGLNENAVVCSERV | 426 | Q8TCU4 | |
| LRNSEDARGVLCEAQ | 391 | O15085 | |
| SDVSSECDREGRQLQ | 6 | O43521 | |
| HSRDEECERVIQGIN | 1141 | Q6RI45 | |
| VSSLQGEDCREAVQR | 56 | Q9GZQ3 | |
| LDFENEGRNAERCAR | 276 | Q3MIX3 | |
| NTACREVGRLREAVA | 861 | Q8N283 | |
| VARALANECSQGDKR | 476 | Q6PL18 | |
| RLVDGNNSCSGRVEV | 156 | Q9NR16 | |
| EQGARRRQAEEDEQC | 321 | Q569K6 | |
| VRCSGQELSRVQEEV | 1526 | Q96SN8 | |
| TLENCTVARCVGDNR | 5021 | Q9HC84 | |
| TAGRIDREEICAQSA | 86 | Q9Y5G6 | |
| QAQGGSSCILREEAR | 31 | Q13133 | |
| QESCAGSDRNFVIDR | 916 | Q8N1W1 | |
| RCEGNFDAIANIRGE | 316 | Q9NPA2 | |
| VNSRIDREELCGQSA | 86 | Q9Y5I1 | |
| GEEQALCVRNRSAFE | 461 | Q9NSA2 | |
| DRVQVLSQDCAVSGD | 41 | Q02779 | |
| CEVAAQRQGVDVARL | 1101 | P46531 | |
| RNNTCIAEGSEDQVL | 3876 | Q9NZR2 | |
| RNASGDELVRCAVDA | 2161 | Q16787 | |
| CANLETAIADAEQRG | 371 | Q86Y46 | |
| QVCQREGSREQEDRG | 1166 | Q6PRD1 | |
| LQCSEREGALQEERA | 846 | Q9BQS8 | |
| RQNGVCTDLDECRVR | 4856 | Q8NDA2 | |
| RECLQGTIRNSQEAE | 306 | Q9BYM8 | |
| DAARTQEDVFRACGV | 71 | Q96FN5 | |
| DDRIFVCNRNGDTCV | 301 | Q07954 | |
| ADIRVLSSQGCRVDN | 216 | P54707 | |
| CQTLQVSVADAEQRG | 376 | P19013 | |
| CARDGQVRVAELINA | 291 | P0C7V8 | |
| ASVLAADTQQCRDGV | 21 | Q5CZC0 | |
| RQDCDVERNRTAAGG | 36 | Q6UXD1 | |
| AARGSCIANAEEVDV | 221 | P29323 | |
| AESRRAVSACQEIQA | 116 | Q9BXM7 | |
| SAEQEGARQLVCNVT | 291 | Q9UMF0 | |
| VCNVTLGGENRETRE | 301 | Q9UMF0 | |
| TETSIDREGLRECQN | 111 | Q08174 | |
| FRVELQTRADGAQCA | 181 | O95206 | |
| QARFQNACRDGRSEI | 41 | Q13951 | |
| LAGRQEASADCQDVI | 431 | Q8IYU2 | |
| READLGEACQSRETV | 1146 | Q5T7B8 | |
| ECQALEGRARAASEQ | 166 | Q9Y6K9 | |
| DLAASCQGRVVAAEE | 516 | Q9UL01 | |
| RAQRQGEEEAECHRQ | 201 | Q96MY7 | |
| QRVVDGCEVAARAAR | 1281 | Q9ULI4 | |
| AQLEQCALQDRESAG | 86 | Q6PGN9 | |
| EAVQIATGRNAARLC | 111 | Q8WWR8 | |
| TARADQEGAREIVCN | 281 | P32942 | |
| DGQICVSQDIDRERD | 721 | Q6V1P9 | |
| ETDRGNRLANNSDCI | 1151 | Q9BX63 | |
| GCTRRLVVQEAGQAD | 1586 | Q5VST9 | |
| NQEAREGATAVLQCE | 3546 | Q5VST9 | |
| QEAREGATAVLQCEL | 3811 | Q5VST9 | |
| VECRNDFLEVRNGSN | 3446 | O60494 | |
| CRDDRERFCENTQAG | 316 | Q92896 | |
| CAFDNRATGREQEAQ | 186 | Q8WWP7 | |
| GCEAVERASAIARQA | 316 | P42357 | |
| ARRQDSDLVQCGVTS | 251 | Q9HC52 | |
| CVEIAREALNAGNRE | 11 | Q8TBM8 | |
| RDEEGVFENNRVTCR | 191 | Q9P0K9 | |
| CENDIDIVRVGDVQR | 86 | O95257 | |
| LAGARRERQEAQGEC | 136 | Q96A19 | |
| TQDESVRRVDVGCLD | 726 | Q2V2M9 | |
| VAQQTRQEADRGCET | 21 | Q9Y264 | |
| GERDNRCNRAHEEAQ | 221 | Q8N144 | |
| NCSALNAEELRRENG | 1431 | O75165 | |
| RVRADEVRLQCQSGS | 71 | Q12852 | |
| AAGELEERFNRALNC | 31 | O95466 | |
| AQRACAEQDGILASA | 181 | Q86UW8 | |
| LRDSEARLAQDQQGC | 136 | Q5VU92 | |
| GAAAEDGRLRVNDCI | 136 | Q15700 | |
| EVRRQCEEGQAASRR | 336 | Q9NT22 | |
| AAAVRDCDQSQTARD | 921 | A2RUR9 | |
| RCCVLQEERDAARAG | 326 | Q8N137 | |
| ARVVLACRSQERGEA | 61 | Q6UX07 | |
| SRFQCIEDRNARLGE | 146 | Q96P20 | |
| DCDDDVQRERNGVIQ | 636 | Q8WU17 | |
| AVQEERDAGVLSRVC | 1246 | Q96Q06 | |
| CNATRENVDRVTEAL | 366 | P21549 | |
| AVQRLSGCQRDAESF | 676 | Q8IYR2 | |
| ADCGVREARAAVRAA | 91 | P51649 | |
| VQTAGEQVADRRNCI | 1551 | O60522 | |
| GQARCAEEARSLRQQ | 56 | O15061 | |
| GQESRLQAEEETRLC | 216 | O15061 | |
| REEVLCQAGASEQLA | 951 | Q8N4C6 | |
| AADERGTQQRRACAN | 26 | P85299 | |
| TGQQSCRQVEELAAE | 241 | Q96MH2 | |
| DRELGQCVNGDSRVE | 966 | Q6IQ23 | |
| RNEIGGECERNVSFS | 431 | O60292 | |
| AVIVTGQGEQCERAR | 161 | Q9UBP0 | |
| GVVCAGQRVANSRDD | 116 | A1L4H1 | |
| ASCRGQAERLQAIQE | 966 | Q9Y2I6 | |
| RDACQRINAGASRKE | 86 | Q68BL8 | |
| VCGHRVERQNRSADD | 121 | A4IF30 | |
| ARAASARGAQVIENC | 221 | Q9UL12 | |
| ARSTACGQQLAEVVE | 556 | Q9NRC6 | |
| EGHCLAQDVEEQARR | 2856 | Q9NRC6 | |
| AQRAEAACAQRSEVE | 526 | P25100 | |
| EGCDQVARDLRAEFS | 46 | Q8N6S5 | |
| RHGNLDEAVEECVRT | 561 | Q96EP0 | |
| RINDRQCTGIEGEDF | 1831 | O75443 | |
| QGTRERLAQAECVLE | 216 | Q86UV6 | |
| VNDCIESGRQAAVSV | 456 | P50336 | |
| AAAVREQEARGTAAC | 206 | Q8N1B4 | |
| EQEARGTAACADVRG | 211 | Q8N1B4 | |
| TREAAQDCEVLGQRI | 411 | P24557 | |
| RRDEDAGEGIQCSQR | 21 | Q9BSA9 | |
| LIQDIERGNRGCESS | 546 | Q9NTN9 | |
| ADRANVVGEVRETCV | 626 | O15027 | |
| QNERGRASCEAVLTV | 111 | Q15772 | |
| QRRDDDGALHAACQV | 51 | P08294 | |
| LDGAFTEENRAQCRA | 1546 | Q9Y490 | |
| ASAEQQEAVCVVRTG | 336 | Q6ZMY3 | |
| ADLQRFQRDCGDASQ | 601 | Q9HBJ7 | |
| DNIEVGICNEAGFRR | 206 | P25787 | |
| QGAQEESRCQRCISE | 1111 | Q15149 | |
| QEAREGTQGERCAVH | 81 | P19474 | |
| FATVSNREQEDLCRG | 466 | Q9P2E3 | |
| GNRREQALEELVACA | 366 | F5GYI3 | |
| VDRSVENCVRACQAA | 746 | Q9Y4G6 | |
| SIDGINRCIRDIEQA | 1666 | Q9Y4G6 | |
| VAAGNSCRQEDVIAT | 2191 | Q9Y4G6 | |
| VAEDNVNELRCGSVN | 36 | Q96JM2 | |
| QGTRERLAQAECVLE | 216 | Q86UV7 | |
| AQSRCGEEIAVQFVD | 291 | O43175 | |
| ANISQAARERDCESV | 1966 | Q12789 | |
| QGTRERLAQAECVLE | 216 | Q86XT4 | |
| DRLQDSGTFQCVARD | 91 | Q13308 | |
| VNEVQASGVELLCDR | 856 | O75962 | |
| AIEGQTVRDQAQRCS | 2006 | Q5THJ4 | |
| ETLCNIDDRDGNRNV | 176 | Q5T7N2 | |
| CAARRQARIDSGSEV | 471 | P22033 |